04/01/2024
5:04 AM | CymaBay Therapeutics (Filer)
| Form 15-12G | |
03/28/2024
11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024
11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024
11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024
11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/28/2024
11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT | |
03/22/2024
3:54 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
|
03/22/2024
3:54 PM | CymaBay Therapeutics (Issuer)
WIGGANS THOMAS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:55 PM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:55 PM | CymaBay Therapeutics (Issuer)
Wills Robert James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:55 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
03/22/2024
3:56 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
03/22/2024
3:58 PM | CymaBay Therapeutics (Filer)
| Form S-8 POS | |
03/22/2024
3:59 PM | CymaBay Therapeutics (Issuer)
Quinlan Paul T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:02 PM | CymaBay Therapeutics (Issuer)
Dickinson Klara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:03 PM | CymaBay Therapeutics (Issuer)
Shantharam Harish (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:03 PM | CymaBay Therapeutics (Issuer)
Dorling Janet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:05 PM | CymaBay Therapeutics (Issuer)
Lefebvre Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:06 PM | CymaBay Therapeutics (Issuer)
McWherter Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:09 PM | CymaBay Therapeutics (Issuer)
Loewy Caroline M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:28 PM | CymaBay Therapeutics (Filer)
| Form POSASR | |
03/22/2024
3:31 PM | CymaBay Therapeutics (Filer)
| Form POSASR | |
03/22/2024
9:53 AM | CymaBay Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
03/22/2024
8:22 AM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
6:50 AM | CymaBay Therapeutics (Subject)
GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/22/2024
6:56 AM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/20/2024
3:24 PM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/20/2024
3:12 PM | CymaBay Therapeutics (Subject)
GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/15/2024
3:11 PM | CymaBay Therapeutics (Subject)
GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/15/2024
3:12 PM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/11/2024
8:14 AM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
03/11/2024
7:34 AM | CymaBay Therapeutics (Subject)
GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T/A | |
03/07/2024
3:35 PM | CymaBay Therapeutics (Subject)
| Form SC 14D9/A | |
02/28/2024
3:31 PM | CymaBay Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/23/2024
5:25 AM | CymaBay Therapeutics (Subject)
| Form SC 14D9 | |
02/23/2024
5:09 AM | CymaBay Therapeutics (Subject)
GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-T | |
02/16/2024
4:14 PM | CymaBay Therapeutics (Subject)
| Form SC14D9C | |
02/15/2024
3:15 PM | CymaBay Therapeutics (Subject)
Menold Daniel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
5:43 PM | CymaBay Therapeutics (Issuer)
Dorling Janet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:46 PM | CymaBay Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
11:50 AM | CymaBay Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
Bill Clinton Backing Biden Replacement??? (Ad) Bill Clinton is back.
And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August… Click here now for my urgent election forecast. |
02/14/2024
8:09 AM | Avoro Capital Advisors LLC (Filed by)
CymaBay Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
4:29 PM | CymaBay Therapeutics (Subject)
| Form SC14D9C | |
02/12/2024
7:42 AM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
7:45 AM | CymaBay Therapeutics (Subject)
| Form SC14D9C | |
02/12/2024
7:39 AM | CymaBay Therapeutics (Subject)
GILEAD SCIENCES, INC. (Filed by)
| Form SC TO-C | |
02/06/2024
4:38 PM | CymaBay Therapeutics (Subject)
STUART LEWIS J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
4:00 PM | CymaBay Therapeutics (Subject)
Menold Daniel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
5:33 PM | CymaBay Therapeutics (Subject)
Menold Daniel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
4:59 PM | CymaBay Therapeutics (Subject)
Menold Daniel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024
5:10 PM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
5:16 PM | CymaBay Therapeutics (Issuer)
Lefebvre Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
5:17 PM | CymaBay Therapeutics (Issuer)
Loewy Caroline M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
5:18 PM | CymaBay Therapeutics (Issuer)
WIGGANS THOMAS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
5:19 PM | CymaBay Therapeutics (Issuer)
Dorling Janet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
5:20 PM | CymaBay Therapeutics (Issuer)
Wills Robert James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
5:27 PM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
5:28 PM | CymaBay Therapeutics (Issuer)
Quinlan Paul T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
5:29 PM | CymaBay Therapeutics (Issuer)
McWherter Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
5:30 PM | CymaBay Therapeutics (Issuer)
Dickinson Klara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
5:33 PM | CymaBay Therapeutics (Issuer)
Shantharam Harish (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
5:59 PM | CymaBay Therapeutics (Issuer)
McWherter Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:33 PM | CymaBay Therapeutics (Subject)
STUART LEWIS J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024
6:15 PM | CymaBay Therapeutics (Subject)
McWherter Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024
3:44 PM | CymaBay Therapeutics (Subject)
STUART LEWIS J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
3:39 PM | CymaBay Therapeutics (Subject)
STUART LEWIS J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
3:54 PM | CymaBay Therapeutics (Subject)
STUART LEWIS J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
6:07 PM | CymaBay Therapeutics (Issuer)
Quinlan Paul T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
6:07 PM | CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:23 PM | CymaBay Therapeutics (Subject)
Menold Daniel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
3:24 PM | CymaBay Therapeutics (Subject)
Quinlan Paul T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024
7:35 PM | CymaBay Therapeutics (Issuer)
Dorling Janet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:11 PM | CymaBay Therapeutics (Subject)
Dorling Janet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2024
3:50 PM | CymaBay Therapeutics (Subject)
STUART LEWIS J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
7:04 PM | CymaBay Therapeutics (Issuer)
McWherter Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
3:35 PM | CymaBay Therapeutics (Issuer)
Quinlan Paul T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
3:38 PM | CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:01 PM | CymaBay Therapeutics (Issuer)
Dorling Janet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:03 PM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:39 PM | CymaBay Therapeutics (Subject)
Shah Sujal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023
4:57 PM | CymaBay Therapeutics (Issuer)
Quinlan Paul T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
4:57 PM | CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
4:58 PM | CymaBay Therapeutics (Issuer)
McWherter Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
4:56 PM | CymaBay Therapeutics (Issuer)
Dorling Janet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
5:00 PM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
8:08 AM | CymaBay Therapeutics (Subject)
Dorling Janet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2023
5:21 PM | CymaBay Therapeutics (Issuer)
Quinlan Paul T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
5:22 PM | CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
5:22 PM | CymaBay Therapeutics (Issuer)
McWherter Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
3:16 PM | CymaBay Therapeutics (Subject)
Quinlan Paul T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2023
3:16 PM | CymaBay Therapeutics (Subject)
Menold Daniel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Bill Clinton Backing Biden Replacement??? (Ad) Bill Clinton is back.
And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August… Click here now for my urgent election forecast. |
10/10/2023
4:04 PM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
7:55 AM | CymaBay Therapeutics (Subject)
Shah Sujal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/29/2023
4:54 PM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
3:54 PM | CymaBay Therapeutics (Subject)
EMSTER KURT VON (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023
3:30 PM | CymaBay Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
09/19/2023
4:23 PM | CymaBay Therapeutics (Issuer)
Quinlan Paul T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
4:25 PM | CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
4:27 PM | CymaBay Therapeutics (Issuer)
McWherter Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:04 PM | CymaBay Therapeutics (Subject)
McWherter Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
